Regulatory compliance
The TGA monitors and enforces regulatory compliance in relation to therapeutic goods. This supports consumer protection and a fair market for industry.
Latest alerts
- Robust Extreme capsulesRobust Extreme capsules pose a serious risk to your health and should not be taken.
- Dark Horse capsulesDark Horse Capsules pose a serious risk to your health and should not be taken.
- Artri King tabletsArtri King tablets pose a serious risk to your health and should not be taken.
Latest articles
- New quality standards for MDMA and psilocybineTwo new quality standards, one for MDMA and another for psilocybine, have been published.
- TGA warns advertising prescription-only weight-loss medicine is prohibitedThe TGA reminds businesses and media outlets that it is unlawful to publicly advertise prescription-only medicines, including prescription-only weight loss medicines.
Telehealth businesses fined over $300,000 for alleged unlawful advertising of weight loss medicinesInfringement notices were issued to businesses and individuals for the alleged unlawful advertising of prescription-only medicines on their websites.
Events and webinars
Latest publications
- Cosmetic injectables: import and supply in AustraliaThis fact sheet is for healthcare practitioners to help understand the rules surrounding importation of cosmetic injectables.
- Therapeutic Goods Advertising and Compliance Education Plan 2024This plan outlines the compliance and education priorities of the Therapeutic Goods Administration for 2024.
- Therapeutic goods advertising compliance: 2022-23 Annual ReportOverview of therapeutic goods advertising complaints handling and compliance for 2022-23